Preoperative anemia in cardiovascular surgery patients

Ozkan S., Kaplan M., Tarcin Ö., Erer H. B., Balci A. Y., Yekeler I.

TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, cilt.19, sa.1, ss.110-115, 2011 (SCI-Expanded) identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 19 Sayı: 1
  • Basım Tarihi: 2011
  • Dergi Adı: TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.110-115
  • Anahtar Kelimeler: Anemia/etiology/therapy, blood transfusion, cardiopulmonary bypass/adverse effects, comorbidity, coronary artery bypass/method, Infection/etiology, postoperative complications, RECOMBINANT-HUMAN-ERYTHROPOIETIN, BLOOD-CELL TRANSFUSION, ACUTE-RENAL-FAILURE, CARDIOPULMONARY BYPASS, POSTOPERATIVE MORBIDITY, MORTALITY, HEMODILUTION, MANAGEMENT, DISEASE, ADULT
  • Marmara Üniversitesi Adresli: Hayır

Özet

Anemia is the most commonly encountered hematological condition during the preoperative evaluation of the cardiovascular surgery patients. Preoperative anemia is associated with an increase in morbidity and mortality in patients who undergo cardiac surgery. In addition, it is the most important determinant of perioperative blood transfusion, with its many risks and side effects. Therefore, determining and treating the reason of preoperative anemia may resolve post-surgical untoward results. Future studies are warranted to determine whether the treatment for anemia administrated before the cardiovascular surgery will resolve postoperative untoward results.